Humphries William D.
CIK 0001674278
Director
Filings
16
Latest Jun 9, 2025
Issuers covered
4
Showing
16 of 16
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 0% | -18.5% | -18.5% | -17.2% | -19.8% |
| 90 days | 2 | 0% | -36.0% | -36.0% | -33.8% | -38.3% |
| 180 days | 2 | 0% | -38.2% | -38.2% | -38.2% | -38.3% |
| 365 days | 2 | 0% | -35.8% | -35.8% | -34.0% | -37.6% |
Issuers
Companies where Humphries William D. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ACRS | Aclaris Therapeutics, Inc. | 5 | Jun 9, 2025 |
| CLSD | Clearside Biomedical, Inc. | 5 | Jun 21, 2024 |
| PHAS | Phasebio Pharmaceuticals Inc | 3 | May 19, 2023 |
| SSKN | Strata Skin Sciences, Inc. | 3 | Jul 7, 2023 |
All filings
16 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|